Randomized, Double-Blinded Evaluation of Rifabutin Based Therapy for Eradication of Staphylococcus Aureus Carriage in HIV Infected Individuals With Prior Skin and Skin Structure Infections.

Trial Profile

Randomized, Double-Blinded Evaluation of Rifabutin Based Therapy for Eradication of Staphylococcus Aureus Carriage in HIV Infected Individuals With Prior Skin and Skin Structure Infections.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 22 May 2013

At a glance

  • Drugs Rifabutin (Primary) ; Cotrimoxazole
  • Indications Skin and soft tissue infections; Staphylococcal infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 22 May 2013 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 15 Jul 2009 Actual initiation date (Jul 2009) added as reported by ClinicalTrials.gov.
    • 15 Jul 2009 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top